CD133-positive bone marrow-derived cell therapy

CD133-positive bone marrow-derived cells · Royan Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD133-positive bone marrow-derived cell therapy, covering 2014-04-25 to 2014-04-25. Get the full timeline:

Most recent: Clinical Trial Update: Multiple Transplantation of Bone Marrow Derived CD133 Cell in Cerebral Palsy [Phase 1, Phase 2]